|
CRLF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.827800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.007350E-01 |
| Normal-vs-Stage2 |
1.461150E-03 |
| Normal-vs-Stage3 |
2.767600E-02 |
| Normal-vs-Stage4 |
4.891800E-02 |
| Stage1-vs-Stage2 |
4.833200E-04 |
| Stage1-vs-Stage3 |
1.505390E-01 |
| Stage1-vs-Stage4 |
3.215000E-01 |
| Stage2-vs-Stage3 |
7.626400E-02 |
| Stage2-vs-Stage4 |
1.329400E-01 |
| Stage3-vs-Stage4 |
9.298200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.694300E-02 |
| Normal-vs-AfricanAmerican |
3.968400E-02 |
| Normal-vs-Asian |
8.930100E-02 |
| Caucasian-vs-AfricanAmerican |
5.171400E-01 |
| Caucasian-vs-Asian |
9.903600E-01 |
| AfricanAmerican-vs-Asian |
6.479400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.989800E-02 |
| Normal-vs-Female |
4.357500E-02 |
| Male-vs-Female |
7.094600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.072800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.843800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.717810E-02 |
| Normal-vs-Age(81-100Yrs) |
5.713200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.418010E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.239800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.477200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.201600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.119000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.493400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.219200E-01 |
| Classical-VS-Follicular |
6.754300E-04 |
| Classical-VS-Other |
3.196000E-01 |
| Classical-VS-Normal |
1.284200E-01 |
| Tall-VS-Follicular |
2.234600E-01 |
| Tall-VS-Other |
6.147600E-01 |
| Tall-VS-Normal |
8.837600E-02 |
| Follicular-VS-Other |
8.831000E-01 |
| Follicular-VS-Normal |
3.255400E-03 |
| Other-VS-Normal |
3.832300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.599500E-03 |
| Normal-vs-N1 |
5.718400E-02 |
| N0-vs-N1 |
2.860000E-01 |
|
|
